Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120543343 | 12054334 | 3 | F | 20160720 | 20160209 | 20160803 | EXP | US-BAYER-2016-022763 | BAYER | 0.00 | A | M | Y | 70.30000 | KG | 20160803 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120543343 | 12054334 | 1 | PS | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | UNK | 21085 | FILM-COATED TABLET | ||||||||||
| 120543343 | 12054334 | 2 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | UNK | 0 | TABLET | ||||||||||
| 120543343 | 12054334 | 3 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | Oral | 50 MG, TID | 0 | 50 | MG | TABLET | TID | ||||||
| 120543343 | 12054334 | 4 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | Oral | UNK | 0 | TABLET | |||||||||
| 120543343 | 12054334 | 5 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | Oral | UNK | 0 | TABLET | |||||||||
| 120543343 | 12054334 | 6 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | UNK | 0 | MODIFIED-RELEASE FILM-COATED TABLET | ||||||||||
| 120543343 | 12054334 | 7 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | UNK | 0 | |||||||||||
| 120543343 | 12054334 | 8 | C | ACETYLSALICYLIC ACID({=100 mg) | ASPIRIN | 1 | 0 | ||||||||||||
| 120543343 | 12054334 | 9 | C | CISPLATIN. | CISPLATIN | 1 | UNK | 0 | |||||||||||
| 120543343 | 12054334 | 10 | C | GABAPENTIN. | GABAPENTIN | 1 | 300 MG, UNK | 0 | 300 | MG | |||||||||
| 120543343 | 12054334 | 11 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120543343 | 12054334 | 2 | Colitis |
| 120543343 | 12054334 | 3 | Colon operation |
| 120543343 | 12054334 | 4 | Liver operation |
| 120543343 | 12054334 | 5 | Colitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120543343 | 12054334 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120543343 | 12054334 | Cardiovascular disorder | |
| 120543343 | 12054334 | Mental disorder | |
| 120543343 | 12054334 | Musculoskeletal injury | |
| 120543343 | 12054334 | Nervous system disorder | |
| 120543343 | 12054334 | Neuropathy peripheral | |
| 120543343 | 12054334 | Pain | |
| 120543343 | 12054334 | Skin injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120543343 | 12054334 | 3 | 201212 | 201302 | 0 | |
| 120543343 | 12054334 | 4 | 20130701 | 20130720 | 0 | |
| 120543343 | 12054334 | 5 | 20140506 | 20140528 | 0 | |
| 120543343 | 12054334 | 9 | 2013 | 2014 | 0 |